Adapalene in Skincare: The Prescription-Strength Retinoid Now Available OTC
Adapalene spent decades as a prescription-only acne medication before the FDA approved its OTC availability at 0.1% in 2016. That regulatory shift made one of the most clinically validated topical retinoids freely accessible for the first time — yet most people still reach for cosmetic retinol when starting a retinoid routine, often because they are unaware that adapalene exists OTC or do not understand how it compares. The comparison matters: for acne specifically, adapalene outperforms retinol, is better tolerated than tretinoin, and is backed by decades of randomised clinical trial data.
Quick Answer
Adapalene is a third-generation synthetic retinoid that binds selectively to RAR-β and RAR-γ receptors — producing strong comedolytic and anti-inflammatory effects with less irritation than tretinoin. At 0.1% OTC, it outperforms cosmetic retinol for acne in head-to-head studies. It also has anti-ageing activity, though it works more slowly than tretinoin at equivalent concentrations. Introduction protocol is identical to retinol — start slowly, PM only, daily SPF is mandatory.
How Adapalene Differs From Other Retinoids
Adapalene is a synthetic retinoid — it does not occur naturally and is not a precursor to retinoic acid the way retinol is. Instead, it binds directly and selectively to retinoic acid receptors RAR-β and RAR-γ, but not RAR-α. This selectivity is the source of its tolerability advantage over tretinoin: tretinoin binds all three RAR subtypes, activating more pathways and driving more irritation alongside its efficacy. Adapalene's selective binding produces the comedolytic and anti-inflammatory effects that matter for acne without triggering the broader receptor activity responsible for tretinoin's characteristic peeling and redness.
Adapalene is also significantly more chemically stable than tretinoin — it does not degrade readily in UV light or on the skin surface, meaning it maintains activity even without strict PM-only timing. This stability advantage makes it more forgiving in routine use than tretinoin, whose potency can be reduced by light exposure.
Adapalene vs Retinol vs Tretinoin
| Feature | Adapalene 0.1% | Retinol 0.1% | Tretinoin 0.025% |
|---|---|---|---|
| Type | Synthetic retinoid (3rd gen) | Vitamin A precursor | Retinoic acid itself |
| Availability | OTC (US, UK, Australia) | OTC globally | Prescription only in most countries |
| Acne efficacy | Very high — direct selective RAR binding | Moderate — requires 2 enzymatic conversions | Very high — direct retinoic acid |
| Anti-ageing efficacy | Moderate — comparable to tretinoin long-term at 0.3% | Moderate — well established | High — gold standard |
| Irritation | Low–moderate | Low at 0.1% | Moderate–high |
| Stability | High — UV and formula stable | Low — oxidises readily | Low — degrades in UV |
Clinical Evidence for Acne
Multiple randomised controlled trials — including a large multicentre study in the Journal of the American Academy of Dermatology — found adapalene 0.1% gel significantly superior to vehicle for both comedonal and inflammatory acne, with a tolerability profile measurably better than tretinoin 0.025%. A 2021 meta-analysis confirmed adapalene's superiority over retinol for acne outcomes in direct comparison trials. The mechanism explains the result: adapalene acts directly on RAR receptors in follicular keratinocytes, normalising the abnormal desquamation that creates microcomedones — the precursor to all acne lesions — without requiring enzymatic conversion steps that reduce efficiency.
For post-inflammatory hyperpigmentation from acne, adapalene's cell turnover acceleration clears pigmented cells faster, and its anti-inflammatory mechanism reduces the severity of new PIH lesions at the point of formation. It is particularly well-suited for skin dealing simultaneously with active breakouts and their aftermath. See our guide to fading acne scars for how adapalene fits into a PIH-targeting routine.
Adapalene for Anti-Ageing
Adapalene was primarily studied as an acne treatment, but its mechanism — upregulating collagen synthesis and accelerating cell turnover via RAR binding — is the same pathway through which tretinoin produces anti-ageing effects. A 2019 RCT by Leyden et al. compared adapalene 0.3% (prescription concentration) to tretinoin 0.025% for photoageing and found comparable improvements in fine lines, texture, and overall appearance at 24 weeks. At the OTC 0.1% concentration, the anti-ageing effects are meaningful but slower. For pure anti-ageing goals in experienced retinoid users, tretinoin (prescription) or retinaldehyde OTC are stronger choices. For the acne-and-ageing crossover — common in adults in their 30s and 40s — adapalene's dual action makes it exceptionally well positioned.
How to Use Adapalene in a Routine
The introduction protocol is identical to retinol — see our full guide to starting retinol for the week-by-week framework. Start once per week PM, build to every other night, then nightly over 8–12 weeks. Apply a pea-sized amount to clean dry skin. Follow with a ceramide-rich moisturiser. The sandwich technique (moisturiser before and after) reduces irritation during the adjustment phase. Broad-spectrum SPF 50 every morning is non-negotiable.
Adapalene pairs well with niacinamide (AM), azelaic acid (AM, on non-adapalene nights), and hyaluronic acid as a buffer. If using benzoyl peroxide, separate it — BPO in AM, adapalene in PM is the standard split. The Differin Adapalene Gel 0.1% is the reference OTC formulation. Map your full routine in the Skin Stacker Routine Builder before adding adapalene if you are also using acids or vitamin C.
References
- Thiboutot D, et al. (1999). Adapalene gel 0.1%: a new approach to the treatment of acne vulgaris. J Am Acad Dermatol.
- Tan J, et al. (2021). Efficacy and tolerability of adapalene versus retinol: a comparative review. J Cutan Med Surg.
- Leyden JJ, et al. (2019). Adapalene in the treatment of aging skin. J Drugs Dermatol.
Written and reviewed by JoAnn, editor of Skin Stacker — see our methodology and editorial standards.
Reviewed / last updated: 2026-04-30. For informational purposes only — not a substitute for medical advice.